Table 4.
L1 n (%) |
L2 n (%) |
L3 n (%) |
L4 n (%) |
Total n (%) |
p Value * | |
---|---|---|---|---|---|---|
Total | 73 | 26 | 4 | 6 | 109 | |
Blood in sputum | 0.9 | |||||
No | 55 (75) | 20 (77) | 4 (100) | 5 (83) | 84 (77) | |
Yes | 18 (25) | 6 (23) | 0 (0) | 1 (17) | 25 (23) | |
Fever > 2 weeks | 0.17 | |||||
No | 34 (47) | 18 (69) | 3 (75) | 4 (67) | 59 (54) | |
Yes | 39 (53) | 8 (31) | 1 (25) | 2 (33) | 50 (46) | |
Unexplained weight loss | 0.35 | |||||
No | 14 (19) | 5 (19) | 2 (50) | 2 (33) | 23 (21) | |
Yes | 59 (81) | 21 (81) | 2 (50) | 4 (67) | 86 (79) | |
Chest Pain | 0.35 | |||||
No | 26 (36) | 9 (35) | 3 (75) | 1 (17) | 39 (36) | |
Yes | 47 (64) | 17 (65) | 1 (25) | 5 (83) | 70 (64) | |
Severity of cough | 0.05 | |||||
Mild | 23 (32) | 8 (31) | 2 (50) | 3 (50) | 36 (33) | |
Moderate | 41 (56) | 10 (38) | 0 (0) | 3 (50) | 54 (50) | |
Severe | 9 (12) | 8 (31) | 2 (50) | 0 (0) | 19 (17) | |
HIV status | 0.46 | |||||
Positive | 3 (4) | 1 (4) | 0 (0) | 1 (17) | 5 (5) | |
Negative | 70 (96) | 25 (96) | 4 (100) | 5 (83) | 104 (95) | |
Type of TB Patient | 0.04 | |||||
New | 70 (96) | 20 (77) | 4 (100) | 6 (100) | 100 (92) | |
Retreated | 3 (4) | 6 (23) | 0 (0) | 0 (0) | 9 (8) | |
BCG | 0.86 | |||||
No | 23 (32) | 8 (31) | 2 (50) | 1 (17) | 34 (31) | |
Yes | 20 (27) | 10 (38) | 1 (25) | 2 (33) | 33 (30) | |
Unknown | 30 (41) | 8 (31) | 1 (25) | 3 (50) | 42 (39) | |
Sputum grading | 0.01 | |||||
Scanty | 0 (0) | 2 (8) | 0 (0) | 0 (0) | 2 (2) | |
1 + | 10 (14) | 9 (35) | 1 (25) | 2 (33) | 22 (20) | |
2 + | 16 (22) | 6 (23) | 1 (25) | 3 (50) | 26 (24) | |
3 + | 47 (64) | 9 (35) | 2 (50) | 1 (17) | 59 (54) | |
Site of TB | 0.81 | |||||
Lung | 69 (95) | 24 (92) | 4 (100) | 6 (100) | 103 (94) | |
Lung plus other | 4 (5) | 2 (8) | 0 (0) | 0 (0) | 6 (6) |
L: lineage; HIV: human immunodeficiency virus; BCG: Bacillus Calmette–Guérin vaccine; * Fisher’s exact test.